The UMass Biohazard Containment Core facility will be comprises of the Virology Core Facility and the Animal Biohazard facility and will operate has a centralized source of reagents for in vitro cell-culture systems and for in vivo animal systems to support the participating CFAR investigators. The Virology Core facility will provide well-characterized stocks of prototypic laboratory strains of primate immunodeficiency viruses. In addition, the facility will provide stocks of well-characterized patient isolates and stocks of viruses obtained from infectious molecular clones. The viral stocks generated in primary CD4 T cells, in monocyte-derived macrophage, or in T cell lines, will be titered and phenotypically characterized for syncytium-inducing properties, replication kinetics and cytopathic properties. Aliquots of the viral stocks will be archived in liquid nitrogen to ensure a constant supply of virus. The Virology Core facility will also supply primary CD4 T cells and macrophages for the CFAR investigators. A FACscan flow cytometer and a FACsort flow cytometer in the facility will be used to analyze cell surface markers and provide aseptically sorted cells. The Animal Biohazard facility will provide animals, technical support and expertise for investigators who wish to use SCID mouse in vivo model systems as a part of their AIDS research. The facility will maintain a BL2+ level of contain that will support a safe and biohazard free environment for work with pathogenic immunodeficient viruses in a rodent model. In addition, the facility will maintain breeding colonies of NOD SCID mice, B2MnullNOD SCID mice, and other strains that may prove to be useful in in vivo studies of immunodeficiency viruses. In summary, the Biohazard Containment Core facility will economize personnel time, eliminate duplication of effort by investigators, enhance the research capabilities of the participating investigators, and function as a central site where collaborative interactions amongst CFAR investigators is fostered/facilitated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042845-03
Application #
6353462
Study Section
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$116,830
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Usami, Yoshiko; Göttlinger, Heinrich (2013) HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep 5:802-12

Showing the most recent 10 out of 122 publications